ClinConnect ClinConnect Logo
Search / Trial NCT02897297

Myeloproliferative Neoplastic Diseases Observatory From Brest

Launched by UNIVERSITY HOSPITAL, BREST · Sep 7, 2016

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial, called the Myeloproliferative Neoplastic Diseases Observatory from Brest, is studying three specific blood disorders: polycythemia vera, essential thrombocythemia, and primary myelofibrosis. The aim is to gather information from patients who are diagnosed or being treated for these conditions at Brest University Hospital. It’s important to note that this is an observational study, meaning that researchers will not be providing any treatment; instead, they will simply be following the health of the patients over time.

Eligible participants are those diagnosed with one of the three conditions mentioned and who agree to take part by signing a consent form. There are no specific exclusions, so anyone meeting the criteria can participate. Throughout the study, patients will be monitored until there are important updates about their health or treatment, such as a change in their care or if they pass away. This study aims to improve understanding of these blood disorders and how they affect patients over time.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with essentiel thrombocythemia, polycythemia vera or primary myelofibrosis
  • Signature of the non-opposition consent form
  • Exclusion Criteria:
  • None

About University Hospital, Brest

The University Hospital of Brest is a leading academic medical center dedicated to advancing healthcare through innovative clinical research and comprehensive patient care. With a strong emphasis on interdisciplinary collaboration, the hospital serves as a hub for cutting-edge clinical trials aimed at improving treatment outcomes across various medical specialties. Leveraging its robust academic affiliations and state-of-the-art facilities, the University Hospital of Brest is committed to fostering scientific discovery and enhancing the quality of life for patients through evidence-based practices and pioneering research initiatives.

Locations

Brest, , France

Patients applied

0 patients applied

Trial Officials

Jean-Christophe Ianotto

Study Director

CHRU de Brest

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials